{"denomUnitsSelected":"Participants","description":"only for patients enrolled in the US","reportingStatus":"NOT_POSTED","timeFrame":"Palbociclib PK assessment: Day 22, Cycle 1, No; Pertuzumab, Trastuzumab PK assessment: Day 1, Cycle 4","title":"Trough Plasma Concentration of Palbociclib, Trastuzumab and Pertuzumab","type":"OTHER_PRE_SPECIFIED"}